Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Metastatic Castration-resistant Prostate Cancer × avelumab × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Transitional Cell 13 Urinary Bladder Neoplasms 12 Neoplasms 8 Carcinoma, Renal Cell 8 Carcinoma, Merkel Cell 8 Neoplasm Metastasis 7 Breast Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 6 Triple Negative Breast Neoplasms 4 Stomach Neoplasms 4 Ovarian Neoplasms 4 Melanoma 4 Carcinoma, Non-Small-Cell Lung 4 Uterine Cervical Neoplasms 3 Ureteral Neoplasms 3 Skin Neoplasms 3 Prostatic Neoplasms 3 Colorectal Neoplasms 3 Urethral Neoplasms 2 Small Cell Lung Carcinoma 2 Sarcoma 2 Head and Neck Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Hepatocellular 2 Urothelial Cancer 1 Turcot syndrome 1 Thymoma 1 Peritoneal Neoplasms 1 Penile Squamous Cell Carcinoma (PSCC) 1 Penile Neoplasms 1

Interventions

Pluvicto 5 olaparib 3 Prednisone 3 Abiraterone Acetate 3 testosterone 17 beta-cypionate 2 radium Ra 223 dichloride 2 enzalutamide 2 darolutamide 2 Prednisolone 2 Docetaxel 2 sipuleucel-T 1 sarilumab 1 rucaparib 1 niraparib 1 lactitol 1 fludarabine phosphate 1 fludarabine 1 fluciclovine F-18 1 enfortumab vedotin 1 ebastine 1 copanlisib 1 cemiplimab 1 cabozantinib 1 cabazitaxel 1 Standard of Care 1 Radium-223 1 PSMA-617 1 Nivolumab 1 Gonadotropin-Releasing Hormone 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡